Resveratrol References

Asensi M, Medina I, Ortega A, et al. (August 2002). "Inhibition of cancer growth by Resveratrol is related to its low bioavailability." Free Radic. Biol. Med.

Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N (May 2006). "Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins." Molecular Cancer Therapeutics 5 (5).

Barger JL, et al. "A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice." Public Library of Science One, 3(6); (2008 June 3).

Bass TM, Weinkove D, Houthoofd K, Gemms D, Patridge L. (2007). "Effects of resveratrol on lifespan in Drosophilia melanogaster and Caenorhabdtitis elegans." Mechanisms of Ageing and Development 128 (10): 546-52.

Baur et al. "Resveratrol improves health and survival of mice on a high-calorie diet." Nature. 2006. 444:337-342.

Baur JA, Sinclair DA (2006). "Therapeutic potential of Resveratrol: the in vivo evidence." Nat Rev Drug Discov 5 (6): 493-506.

Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellon EA (Oct 18 2006). "Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines." Journal of Andrology.

Bertelli AA, L. Giovanni, et al. (1996). "Kinetics of trans- and cis-resveratrol (3,4’,5-trihydroxyatilbene) after red wine oral administration in rats." International 16(4-4): 77-81.

Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM (2001). "Estrogenic and antiestrogenic properties in resveratrol in mammary tumor models." Cancer Res. 61 (20): 7456-63.

Bishayee A. "Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials." Cancer Prevention Research (Philadelphia, Pa.). 2009 Apr 28. [Epub ahead of print]

Boocook DJ, Faust, GE, Patel KR, et al. (June 2007). "Phase I dose escalation pharmacokinetic study in healthy volunteers of Resveratrol, a potential cancer chemopreventive agent." Cancer Epidemiol. Biomarkers Prev. 16 (6): 1246-52.

Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. "Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta." Endocrinology 2000 Oct;141(10):3657-67.

Bråkenheim, E, Cao R, Cao Y (August 2001). "Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes." Faseb J. 15 (10) 1798-800.

Cao Y, Fu ZD, Wang F, Liu HY, Han R (2005). "Anti-agiogenic activity of resveratrol, a natural compound from medicinal plants." Journal of Asian Natural Products Research 7 (3): 205-13.

Chun YJ, Kim MY, Guengerich FP (1999). "Resveratrol is a selective human cytochrome P450 1A1 inhibitor." Biochem. Biophys. Res. Commun. 262 (1): 20-4.

De la Lastra CA, Villegas I. "Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications." Mol Nutr Food Res. 2005 May;49(5):405-30

Ector BJ, Magee JB, Hegwood CP, Coign MJ. "Resveratrol Concentration in Muscadine Berries, Juice, Pomace, Purees, Seeds, and Wines." http://www.ajevonline.org/cgi/content/abstract/47/1/57

Faber AC, Chiles TC (Dec 2006). "Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: Evidence for a novel mechanism involving inhibition of BCL6 signaling." International Journal of Oncology 29 (6).

Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ. "Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells." Antiviral research 2006 Jul 14

Gao, DK, X. Zhang, et al. (2006) "Resveratrol reduces the elevated level of MMP-9 by cerebral ischemia-reperfusion in mice." Life Sciences 78 (22): 25642570.

Garvin S, Ollinger K, Dabrosin C (January 2006)."Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo." Cancer Lett. 231 (1): 113-22.

Gautam R, Jachak SM. "Recent developments in anti-inflammatory natural products." 2009. Medicinal Research Reviews. 2009 Apr 17. [E pub ahead of print]

Gehm BD, McAndrews JM, Chien P, Jameson JL. "Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor." Proc. National. Academy of Sciences 1997 Dec 9; 94(25):14138-43.

Gescher AJ, Steward WP. "Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum." Cancer Epidemiol Biomarkers Prev. 2003;12(10):953-957.

Gu X, Creasy L, Kester A, et al., "Capillary electrophoretic determination of resveratrol in wines. J Agric Food Chem 47:3323-3277, 1999

Harper et al., "Resveratrol suppresses prostate cancer progression in transgenic mice." Journal of Carcinogenesis. 2007. 28 (9):1946-1953.

Gruber J, Tang SY, Halliwell B (April 2007). "Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans." Ann N Y Acad Sci. 1100: 530-42.

Heredia A, Davis C, Redfield R. "Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol." J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):246-55.

Howitz et al., "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan." Nature. 2003. 425(6954):191-6.

Hudson,TS, Hartle DK, Hursting SD, et al. (September 2007). "Inhibition of prostate cancer growth by muscadine grape skin extract and Resveratrol through distinct mechanisms." Cancer Res. 67 (17): 8396-405.

Hung LM, Chen JK, Huang SS, Lee RS, Su MJ (2000). "Cardioprotective effect of Resveratrol, a natural antioxidant derived from grapes." Cardiovasc. Res. 47 (3): 549-55.

Inanaga et al. "Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis." Hypertension Research. 2009. Apr 17. [Epub ahead of print]

Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997). "Cancer chemopreventive activity of Resveratrol, a natural product derived from grapes." Science 275 (5297): 218-20.

Kaeberlein M et al. "Sir2-independent life span extension by calorie restriction in yeast." PLoS Biol. 2004 Sep;2(9):E296.

Kaeberlein M et al. "Substrate-specific activation of sirtuins by resveratrol." J Biol Chem. 2005 Apr 29; 280(17):17038-45.

Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE (November 2008). "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease." Neurochem Int. 54: 111.

Kimura Y, Okuda H (June 2001). "Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and mestatasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice." J. Nutr. 131 (6): 1844-9.

Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I (March 2008). "Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells." Am J Physiol Lung Cell Mol Physiol. 294 (3): L478-8.

Lagouge et al. "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha." Cell. 2006. 127(6):1109-22.

Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C (April 2005). "Resveratrol and Breast Cancer Risk." Eur J Cancer Prev. 14 (2): 139-42.

Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y, Kaganoi J, Hashimoto Y, Imamura M (2002). Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol." Carcinogenesis 23 99): 1531-6.

Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C (April 2005). "Resveratrol and breast cancer risk." Eur J Cancer Prev. 14 (2): 139-42.

Marambaud P. "Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides." Journal of Biological Chemistry. 2005. 280(45):37377-82.

Olas, B, B. Wachowicz, et al. (2001). "The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin." Microbios 105(410): 7-13.

Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG. "Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol." Am J Physiol Heart Circ Physiol 2005 Mar;288(3):H1131-8.

Palamara AT, Nencioini L, Aquilano K, et al. "Inhibition of influenza A virus replication by Resveratrol". Journal of Infectious Diseases May 2005 15;191(10):1719-29.

Palsamy P, Subramanian S (2008). "Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats." Biomed Pharmacother 62 (9): 598-605.

Palsamy P, Subramanian S (2009) "Modulatory effects of Resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-incotinamide induced diabetic rats." Chem Biol Interact 179 (2-3): 356-62.

Parker JA, et al. "Resveratrol rescues mutant polyglutamine cytotoxicity in C. elegans and mammalian neurons." Nature Genetics. 2005. 4:349-50.

Riles WL, Erickson J, Nayyar S, Atten MJ, Attar BM, Holian O (21 Sep 2006). "Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells." World Journal of Gastroenterology 12 (35).

Robb EL, Page MM, Wiens BE, Stuart JA (March 2008). "Molecular mechanisms of oxidative stress resistance induced by Resveratrol: Specific and progressive induction of MnSOD." Biochem Biophys Res Commun. 367 (2): 406-12.

Roy et al. "Resveratrol Enhances Ultraviolet B-Induced Cell Death through Nuclear Factor-kappa B Pathway in Human Epidermoid Carcinoma A431 Cells." Biochemical and Biophysical Research Communications. 2009. [Epub ahead of print]

Saiko P, Horvath Z, Murias M, Handler N, Jaeger W, Erker T, Fritzer-Szekeres M, Szekeres T. "Antitumor Effects of 3,3',4,4',5,5'-Hexahydroxystilbene in hl-60 Human Promyelocytic Leukemia Cells." Nucleosides Nucleotides Nucleic Acids 25 (9).

Sareen D, van Ginkel PR, Takach JC, Mohiuddin A, Darjatmoko SR, Albert DM, Polans AS (Sep 2006). "Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells." Investigative Ophthamology & Visual Science 47 (9).

Sinclair, David A., et al. "Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase." Science 305 (July 16 2004): 309-392.

Stefani M, et al. (October 2007) "The effect of resveratrol on a cell model of human aging." Ann N Y Acad Sci. 1114: 407-18.

Stewart JR, Artime MC, O’Brian CA (01 July 2003). "Resveratrol: a candidate nutritional substance for prostate cancer prevention." J Nutr. 133 (7Suppl): 2440S-2443S.

Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, Lin HY (Aug 2006). "Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells." 5 (8).

Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A "Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived Vertebrate." Current Biology 2006 Feb 7;16 (3):296-300

Vitaglione P, Sforza S, Galaverna G, et al. (May 2005). "Bioavailability of trans-resveratrol from red wine in humans." Mol Nutr Food Res 49 (5): 495-504.

Wang LX, Heredia A, Song H, et al. (October 2004). "Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity." J Pharm Sci 93 (10) 2448-57.

Wang Y, Lee KW, Chan FL, Chen S, Leung LK (2006). "The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells." Toxicol Sci. 92 (1): 71-7.

Wenzel, E, Soldo T, Erbersdobler H, Somoza V. (May 2005). "Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats." Mol Nutr Food Res. 49 (5): 482-94.

Wenzel E, Somoza, V (May 2005) "Metabolism and bioavailablity of trans-resveratrol." Mol Nutr Food Res 49 (5): 472-81.

Whitsett TG Jr, Lamartiniere CA. "Genistein and Resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat." Expert Rev Anticancer Ther. 2006 Dec;6(12):1699-706.

Wolf, George. "Calorie Restriction Increases Life Span: A Molecular Mechanism." Nutrition Reviews 64.2 (Feb. 2006): 89-92

Wood JG, Rogina B, Lavul S, Howitz K, Helfand SL, Tatar M, Sinclair D (2004). "Sirtuin activators mimic caloric restriction and delay aging in metazoans." Nature 430 (7000): 686-9.

Yu C, Shin YG, Chow A. et al. (December 2002). "Human, rat, and mouse metabolism of Resveratrol." Pharm Res. 19 (12): 1907-14.